ACADIA PHARMACEUTICALS A/S: Financial statements 2016
CVR: 19670694
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -44,570 compared with DKK -56,389 the year before. Equity in the 2016 report amounted to DKK -314,830.
- Profit/Loss
- DKK -44,570
- Equity
- DKK -314,830
- Total Assets
- DKK 4,195
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -45 t. | -315 t. | - |
| 2015 | - | - | -56 t. | -270 t. | - |
| 2014 | - | - | -147 t. | -214 t. | - |
| 2013 | - | - | -57 t. | -67 t. | - |
| 2012 | - | - | -258 t. | -10 t. | - |
Official annual report
Find more companies like ACADIA PHARMACEUTICALS A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ACADIA PHARMACEUTICALS A/S has published its annual report for 2015. The net result was DKK -56,389.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.